Supporting community and civil society engagement in the IAS COVID-19 Prevention Conference
28 & 29 January 2021
The African Alliance, the Vaccine Advocacy Resource Group, the Global Network of Young People Living with HIV (Y+ Global) and the READY Movement bring you a series of lectures focusing on the four pillars of the International AIDS Society’s “COVID-19 Conference: Prevention” held on the 2nd February 2021. The Conference featured the latest in prevention-related science, policy and practice and examined all aspects of SARS CoV-2 infection.
Watch the full sessions here:
Dr. Nyaradzo Chigorimbo-Tsikiwa – University of Cape Town
28 January 2021, 16:00 – 18:00 SAST
Dr Nyaradzo Chigorimbo-Tsikiwa is a senior researcher in the department of Medical Virology at the University of Cape Town. She heads a small research group which investigates the interaction of viruses with the human body, specifically looking at ways to prevent infection. Prior to that she was an early career research fellow at UCT and the Desmond Tutu HIV foundation. She completed her post- doctoral fellowship in 2013 in Drug Discovery in which she was part of the multidisciplinary team that developed the first African clinical candidate which was developed using modern drug discovery paradigms. She is passionate about home grown African solutions and interventions to tackle African problems. Dr Chigorimbo-Tsikiwa currently uses multidisciplinary biomedical approaches to understanding and finding solutions to prevent HIV infection. She works with several international collaborators and has presented her work internationally to scientific conferences and forums as well as the public.
GLOBAL ACCESS AND POLICY
Dr. Jenniffer Mabuka-Maroa – African Academy of Sciences
28 January 2021, 18:00 – 20:00 SAST
Dr Jenniffer Maroa heads the genetics program Human Heredity and Health In Africa (H3Africa) and the African Human Clinical Trials portfolio of The African Academy of Sciences (The AAS). Prior to joining the AAS, Maroa spent 16 years doing HIV-1 clinical research. She investigated host immune responses in mother-to-child transmission of HIV-1 with a focus on breast-milk transmission and explored antibody evolution in natural HIV-1 infection with the goal of informing antibody-based vaccine design. Dr Maroa holds a PhD from the University of Washington’s department of Global Health, and is currently a Clinical Associate Professor at the University of Washington in Seattle and a 2018 Aspen New Voices Fellow.
NONPHARMACEUTICAL INTERVENTIONS (NPIS)
Dr. Sibusiso Mkwananzi – University of Johannesburg
29 January 2021, 16:00 – 18:00 SAST
Dr. Sibusiso Mkwananzi is a demographer and senior researcher with a background in health. She holds a PhD in Demography, Masters in Epidemiology & Biostatistics as well as an undergraduate degree in Dentistry. Her research interests lie in the application of quantitative research methods to traditionally qualitatively approached issues such as gender, intersectionality, sexual and reproductive health and rights, gender-based violence, development as well as the nexus of social and health phenomena.
Dr. Samukeliso Dube – Hugiano Health Group
29 January 2021, 18:00 – 20:00 SAST
Dr. Dube’s 20 years’ experience in health care has included several senior roles in the delivery and financing of health care, the latest of which was at Philips Healthcare as a Medical Counsel for Africa and Business Development Manager for Southern Africa. Dr Dube worked at ArK as head of Healthcare Investments prior to which she was Africa Director at PATH.